Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial
Background. Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. Objective. To investigate whether social app could be used to reduce warfarin-associated adverse events among post-MHVR Chinese patients. Met...
Main Authors: | Litao Zhang, Sha Li, Zishuo Li, Dan Yu, Haiyan Wu, Bing Hua, Li Xie, Xia Yuan, Yun Li, Zhenlu Zhang, Yanli Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2023-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2023/2342111 |
Similar Items
-
Warfarin dosage response related pharmacogenetics in Chinese population.
by: Siyue Li, et al.
Published: (2015-01-01) -
Plasma miRNA profiles associated with stable warfarin dosage in Chinese patients
by: Li Zhao, et al.
Published: (2020-10-01) -
Standardization of D‐dimer reporting in the COVID‐19 era
by: Litao Zhang, et al.
Published: (2022-08-01) -
Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement.
by: Li Zhao, et al.
Published: (2014-01-01) -
The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular
Atrial Fibrillation
by: Hongxia Li, et al.
Published: (2021-09-01)